Dr Dow stated that he thought surrogate testing would have been likely to reduce the incidence of post-transfusion NANBH in Scotland by 70 percent.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr Brian Charles Dow